MCM
ALNY icon

Moore Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Moore Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,104
Closed -$1.87M – 674
2025
Q3 		$1.87M Buy
+4,104
New +$1.67M 0.04% 370
2024
Q1 		– Sell
-4,635
Closed -$887K – 443
2023
Q4 		$887K Sell
4,635
-17,350
-79% -$2.96M 0.02% 284
2023
Q3 		$3.89M Buy
+21,985
New +$4.19M 0.11% 192
2023
Q1 		– Sell
-10,000
Closed -$2.38M – 490
2022
Q4 		$2.38M Sell
10,000
-11,247
-53% -$2.4M 0.07% 252
2022
Q3 		$4.25M Buy
+21,247
New +$4.05M 0.12% 225
2015
Q2 		– Sell
-5,500
Closed -$574K – 413
2015
Q1 		$574K Buy
+5,500
New +$557K 0.02% 380

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM